Filing Details

Accession Number:
0000884731-16-000057
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-13 17:59:59
Reporting Period:
2016-05-12
Filing Date:
2016-05-13
Accepted Time:
2016-05-13 17:59:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1662996 Paris Panayiotopoulos 26 Landsdowne Street
Cambridge MA 02139
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-05-12 26,990 $7.41 88,089 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 61,099 Direct
Footnotes
  1. The reporting person purchased the shares of common stock in a private transaction with the Company pursuant to the terms of his employment agreement and a related subscription agreement, as summarized in the Current Report on Form 8-K filed by the Company on December 18, 2015. The current purchase of $200,000 worth of common stock, together with a prior purchase of $300,000 of common stock on February 1, 2016, fulfills the reporting person's agreement to purchase an aggregate of $500,000 worth of common stock from the Company at market price within the first year of his employment.